Medical Mass Spectrometry
Online ISSN : 2432-745X
Print ISSN : 2432-7441
ISSN-L : 2432-7441
Mini Review
GC/MS/MS-based targeted metabolomics for pathophysiological analysis of animal models
Kei Zaitsu Yumi Hayashi
著者情報
ジャーナル フリー

2019 年 3 巻 1 号 p. 11-18

詳細
抄録

Metabolomics is an essential tool for not only understanding the pathophysiology of various diseases but also for searching for initial clues to unknown toxic effects of drugs. Mass spectrometry-based metabolomics has achieved highly sensitive and selective analysis of metabolites, and gas chromatography mass spectrometry remains a gold standard because of its robustness and usability. However, it is tedious to annotate metabolites with electron ionization (EI)-based mass spectra; thus, gas chromatography tandem mass spectrometry (GC/MS/MS)-based metabolome analysis has played an important role in metabolomics. In particular, the selected reaction monitoring (SRM) mode achieves higher selectivity and an improved signal-to-noise ratio, which leads to easier metabolite identification. In this mini review, we concisely outline the pros and cons of GC/MS/MS-based metabolome analysis and provide its applications to pathophysiological analysis of disease and drug-induced toxicity in animal models based on our previous studies. Finally, future perspectives for newly developed high-throughput metabolome analysis are briefly described.

著者関連情報
© 2019 Japanese Society for Biomedical Mass Spectrometry

この記事はクリエイティブ・コモンズ [表示 - 非営利 - 改変禁止 4.0 国際]ライセンスの下に提供されています。
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja
前の記事 次の記事
feedback
Top